Condition

Epilepsy (Treatment Refractory) clinical trials and research

As of November 12, 2026, Find a Trial lists 4 Epilepsy (Treatment Refractory) clinical trials that are recruiting, at sites in 2 countries (most in United States (3), China (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Epilepsy (Treatment Refractory) clinical trials

StudyPhaseWhereStatusRegistered
Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy — San Francisco, California Recruiting Jul 2, 2026
Long-term follow-up of the Minder implanted EEG system for epilepsy care — Birmingham, Alabama and 20 other locations Recruiting Aug 7, 2025
Minder sub‑scalp EEG to improve diagnosis and care for epilepsy — Birmingham, Alabama and 22 other locations Recruiting Aug 7, 2025
Closing a heart opening to treat drug-resistant epilepsy — Chengdu, Sichuan Recruiting Mar 7, 2025

All recruiting trials (4)

Related topics

EpilepsyDrug Resistant EpilepsyEpilepsy, Drug ResistantEpilepsy, Generalized

Quick answers

How many Epilepsy (Treatment Refractory) clinical trials are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (3 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.